Mölndal, Sweden

Marianne Swanson

USPTO Granted Patents = 9 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Mölndal, SE (2003 - 2011)
  • Gothenberg, SE (2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Marianne Swanson

Introduction

Marianne Swanson is a prominent inventor based in Mölndal, Sweden. With a remarkable portfolio of nine patents, she has made significant contributions to the fields of pharmaceuticals and medicinal chemistry. Her work primarily focuses on developing novel compounds that address critical health conditions.

Latest Patents

Marianne's latest patents include groundbreaking innovations such as N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides. This patent encompasses compounds that demonstrate potential in treating or preventing conditions related to Prolyl endopeptidase fibroblast activation protein (FAP). Additionally, she has worked on pharmaceutical compositions that incorporate these compounds and methods for their production.

Another key patent patented by Marianne is for non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides, recognized for their role as liver X receptor modulators. This invention includes a variety of novel compounds that could be beneficial in treating clinical conditions such as cardiovascular diseases, inflammation, Alzheimer's disease, and other metabolic syndrome manifestations.

Career Highlights

Marianne Swanson has built a reputable career as an inventive force in the pharmaceutical industry. Her tenure at AstraZeneca AB has afforded her the opportunity to contribute to vital research and development initiatives that target pressing health issues. Marianne's dedication to her field is reflected in her extensive patent portfolio.

Collaborations

Throughout her career, Marianne has collaborated with esteemed colleagues including Thomas Elebring and Peter Guzzo. These partnerships have enabled her to leverage diverse expertise and drive forward innovative solutions in her research endeavors.

Conclusion

Marianne Swanson’s contributions to the landscape of pharmaceuticals through her patented inventions demonstrate her passionate commitment to advancing healthcare solutions. Her innovative spirit continues to inspire and pave the way for future breakthroughs in the industry. It is clear that her work will have a lasting impact on medical science and the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…